Clinical Trial Update: Hypertonic Saline in Posterior Spinal Fusion [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating hypertonic saline in posterior spinal fusion for scoliosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Scoliosis
• Idiopathic Scoliosis

Drugs mentioned

• Hypertonic Saline (Hypertonic saline)

Snippet

Sponsor: Joseph D. Tobias | Conditions: Scoliosis Idiopathic, Scoliosis;Congenital | Phase 2, Phase 3 | Status: WITHDRAWN